Max Healthcare Institute Limited (MAXHEALTH) — Board Meeting | 13 August 2025

· NSE 🟡 Notable ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Max Healthcare reported Q1 FY26 consolidated revenue of ₹202,757 lakhs and net profit of ₹30,797 lakhs, with basic EPS of ₹3.17. The board approved a strategic expansion in Dehradun involving a ~130-bed oncology hospital with capex of ₹170-200 crores, leveraging >80% existing occupancy. Max also completed the ₹62,470 crore acquisition of Jaypee Healthcare in FY25 and maintains a network of ~5,200 beds across 14 subsidiaries with >76% Q1 utilization.

📄 View Original Announcement (PDF)

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXHEALTH — Free

Free account · 2 AI queries/day